Similarly, vital immune checkpoint genes such as HAVR2, CD274, CTLA4, ITGB2, ICAM1, CCL5, CXCL10 all exhibited robust correlation with IFI30, and this immunotherapy might, in the future, establish a bond with IFI30, bringing new opportunities for cancer treatment. This evidence concerns the gene CD274 and cancer.